By Matthew Herper , Nicholas Florko and Helen Branswell Plans to attempt to authorize the Pfizer/BioNTech Covid vaccine for children under 5 before full data are available appear to have run aground. The Food and Drug Administration on Friday canceled a key meeting...
Pfizer and FDA pull back from plan to expedite review of Covid-19 vaccine in young children
read more